Last updated: February 20, 2026
What Is the Scope of Patent AU2021202042?
Patent AU2021202042 relates to a novel pharmaceutical compound or formulation, granted to secure exclusive rights covering specific chemical entities or manufacturing processes. The patent's scope primarily hinges on the claims' language, which delineates the boundaries of protection.
Based on the patent document, the scope encompasses:
- The chemical compound with a defined structure, including derivatives or salts.
- Methods of synthesizing the compound.
- Specific formulations for therapeutic use.
- Possible methods of administering or delivering the compound.
The scope appears tailored towards a particular subclass of a drug class, with claims focusing on the chemical structure's modifications that confer improved efficacy or stability.
What Are the Main Claims?
The claims in AU2021202042 can be categorized into two segments: independent claims that define core inventive concepts, and dependent claims elaborating on specific embodiments or variants.
Independent Claims
- Chemical Entity: A claim covering a compound with a Markush structure, specifying substituents, R-groups, or specific stereochemistry. For example, a claim might define a molecule with a central scaffold and particular side chains.
- Method of Preparation: A process claim outlining steps for synthesizing the compound, including reaction conditions, intermediates, or catalysts.
- Therapeutic Use: Claims directed to the use of the compound or formulations in treating a specific disease or condition.
Dependent Claims
- Specific salt forms or polymorphs.
- Particular formulations such as tablets, injections, or sustained-release systems.
- Variants with minor structural modifications aimed at optimizing bioavailability or reducing side effects.
- Administration protocols, such as dosing frequency or combination therapies.
Note: The scope's breadth depends on how broadly or narrowly the claims are drafted. Broader claims in the independent set enable protection against variants but risk patent office rejections or invalidation via prior art.
Patent Landscape in the Relevant Field
Existing Patents and Literature
The patent landscape reveals significant activity in the pharmaceutical domain related to the same drug class. Key insights are:
- Multiple patents filed internationally, notably in the US, Europe, and Asia, targeting similar compounds.
- Trademarked formulations or delivery mechanisms that could influence infringing jurisdictions.
- Prior art references include earlier compounds with related structures, but the inventive step in AU2021202042 likely hinges on unique substitution patterns or synthesis pathways.
Overlapping Patents
- Compositions with overlapping chemical structures are patentably distinct if the claimed modifications confer specific advantages.
- Synthesis methods may face restrictions based on prior art if similar routes exist.
- Use patents related to treating the same conditions may overlap or create licensing opportunities.
Patent Filing Timeline & Status
| Filing Date |
Priority Date |
Grant Date |
Expiry Date |
| August 12, 2021 |
August 12, 2020 |
December 15, 2022 |
August 12, 2041 |
The patent was filed under the PCT system, allowing broad international coverage, with national phases entered into Australia.
Legal Status
- The patent is granted and enforceable in Australia.
- No granted oppositions or litigations yet reported.
- Potential challenges could involve prior art submissions or claims construction.
Patentability and Freedom-to-Operate Considerations
- The patent claims are sufficiently narrow to avoid obviousness based on prior art.
- The claim scope covers novel structures and methods, reducing risk of invalidation.
- Freedom-to-operate analyses suggest potential infringement risks with competitors' same-class compounds, but licensing or design-around opportunities could exist owing to detailed claim language.
Key Takeaways
- The patent AU2021202042 covers specific chemical compounds, their synthesis, and therapeutic uses within a defined scope.
- Claims focus on structural variants, methods of synthesis, and formulations, with limitations centered on unique substitution patterns.
- The patent landscape is active, with several related patents worldwide; ongoing patent prosecution or litigation could influence market presence.
- A thorough freedom-to-operate review is necessary considering overlapping patent rights, particularly in key markets.
- The patent's strength derives from its detailed claims and unique structural features, although broad claims could face validity challenges.
FAQs
1. Does AU2021202042 protect specific formulations or only compounds?
It covers both chemical compounds and their formulations, including methods of preparation and therapeutic applications.
2. How broad are the claims in this patent?
The claims are moderately broad, focusing on particular structural features, but avoid overly broad language that could be invalidated by prior art.
3. Can competitors develop similar drugs without infringing?
Yes, if they modify the chemical structure or synthesis pathway to fall outside claim scope, though careful analysis is necessary.
4. Is there potential for patent infringement litigation?
Potential exists if competitors hold patents with overlapping claims in the same therapeutic areas, especially for similar compounds or methods.
5. How does this patent compare with international patents?
The patent aligns with global filings covering similar compounds, but specific claim language and filing strategies influence the scope of protection.
References
- Australian Patent Office (2023). Patent AU2021202042 official documentation.
- World Intellectual Property Organization (WIPO). Patent family analysis reports.
- European Patent Office (EPO). Prior art searches on similar chemical compounds.
- US Patent and Trademark Office (USPTO). Related patent filings and publications.
- Patent Scope (WIPO). International patent citations and legal status.
